BioSymetrics vs Cellcolabs
BioSymetrics vs Cellcolabs, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BioSymetrics is on 63/100 and Cellcolabs on 55/100.
Where each one leads
BioSymetrics
- our overall score: 63/100 against 55/100
- agent readiness: 46/100 against 40/100
Cellcolabs
- domain rating: 37/100 against 30/100
- headcount: 79 against 14
- funding raised: $15.5M against $6.6M
- LinkedIn following: 6,563 against 3,571
At a glance
| Measure | BioSymetrics | Cellcolabs |
|---|---|---|
| What it is | Phenomics-driven AI company translating disease biology into precision medicine discoveries. | AI-powered platform for personalized cell therapy development and manufacturing. |
| Category | Biotech, HealthTech, Drug Discovery, Genomics | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2021 |
| Headquarters | Boston, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | BioSymetrics | Cellcolabs |
|---|---|---|
| Employees | 14 | 79 |
| Headcount growthLast 12 months | +139.3% | Not published |
| Total funding | $6.6M | $15.5M |
| Latest round | Seed | Not published |
| LinkedIn followers | 3,571 | 6,563 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BioSymetrics | Cellcolabs |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 63/100 | 55/100 |
| Team | 96/100 | Not published |
| Search visibility | 64/100 | 2/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 30/100 | 37/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BioSymetrics | Cellcolabs |
|---|---|---|
| CDN | Not detected | Cloudflare |
| Analytics | Not detected | Google Tag Manager |
| Open source | Yes | No |
BioSymetrics vs Cellcolabs: common questions
Which is better, BioSymetrics or Cellcolabs?
On our 0-100 score BioSymetrics rates higher (63/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do BioSymetrics and Cellcolabs compare on the numbers?
BioSymetrics leads on our overall score (63/100 against 55/100), agent readiness (46/100 against 40/100). Cellcolabs leads on domain rating (37/100 against 30/100), headcount (79 against 14), funding raised ($15.5M against $6.6M), LinkedIn following (6,563 against 3,571).
Read the full BioSymetrics review and pricing or the Cellcolabs review and pricing. You can also browse other BioSymetrics alternatives we track.